Drug-induced movement disorders

被引：25
|
作者：
Duma, Stephen R. [1 ]
Fung, Victor S. C. [2 ]
机构：
[1] Westmead Hosp, Movement Disorders Unit, Dept Neurol, Sydney, NSW, Australia
[2] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
来源：
AUSTRALIAN PRESCRIBER | 2019年 / 42卷 / 02期
关键词：
dystonia; neuroleptic malignant syndrome; parkinsonism; serotonin syndrome; tardive dyskinesia; EXTRAPYRAMIDAL SYNDROMES; INTERNATIONAL CONSENSUS; DIAGNOSTIC-CRITERIA; TARDIVE-DYSKINESIA;
D O I：
10.18773/austprescr.2019.014
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Many therapeutic and illicit drugs can cause movement disorders. Antipsychotics and antiemetics are most commonly implicated. The time of onset of the movement disorder may be acute, subacute, or chronic. The severity can range from mild to severe and life-threatening. Early recognition of a drug-induced movement disorder is essential to allow for prompt intervention. This includes stopping the offending drug, supportive care, and sometimes other pharmacological treatment.
引用
收藏
页码：56 / 61
页数：6
相关论文
共 50 条
  • [1] Drug-induced movement disorders
    Zadori, Denes
    Veres, Gabor
    Szalardy, Levente
    Klivenyi, Peter
    Vecsei, Laszlo
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (06) : 877 - 890
  • [2] Drug-induced movement disorders
    Diederich, NJ
    Goetz, CG
    NEUROLOGIC CLINICS, 1998, 16 (01) : 125 - +
  • [3] Drug-induced movement disorders
    Rodnitzky, RL
    CLINICAL NEUROPHARMACOLOGY, 2002, 25 (03) : 142 - 152
  • [4] Drug-Induced Movement Disorders
    Pandey, Sanjay
    Pitakpatapee, Yuvadee
    Saengphatrachai, Weerawat
    Chouksey, Anjali
    Tripathi, Madhavi
    Srivanitchapoom, Prachaya
    SEMINARS IN NEUROLOGY, 2023, 43 (01) : 35 - 47
  • [5] Drug-Induced Movement Disorders
    Félix Javier Jiménez-Jiménez
    Pedro José García-Ruiz
    José Antonio Molina
    Drug Safety, 1997, 16 : 180 - 204
  • [6] DRUG-INDUCED MOVEMENT DISORDERS
    NORTH, RR
    POSTGRADUATE MEDICINE, 1971, 50 (03) : 180 - &
  • [7] Drug-induced movement disorders
    JimenezJimenez, FJ
    GarciaRuiz, PJ
    Molina, JA
    DRUG SAFETY, 1997, 16 (03) : 180 - 204
  • [8] Drug-induced Movement Disorders
    Mehta, Shyamal H.
    Morgan, John C.
    Sethi, Kapil D.
    NEUROLOGIC CLINICS, 2015, 33 (01) : 153 - +
  • [9] DRUG-INDUCED MOVEMENT-DISORDERS
    GERSHANIK, OS
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1993, 6 (03): : 369 - 376
  • [10] DRUG-INDUCED MOVEMENT-DISORDERS
    OWEN, RT
    PHARMACY INTERNATIONAL, 1980, 1 (09): : 181 - 183
12345